Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 415

Mosa Meat starts cooking up series B

Bell Food Group and M Ventures have contributed to an initial $55m series B tranche for the cultured meat developer spun out of Maastricht University.

Sep 30, 2020

Mosa Meat starts cooking up series B

Bell Food Group and M Ventures have contributed to an initial $55m series B tranche for the cultured meat developer spun out of Maastricht University.

Sep 30, 2020

UpShow entertains $14m series A

4490 Ventures, a VC firm aligned to University of Wisconsin-Madison, backed a series A extension intended to advance in-venue digital marketing technology company UpShow's product and recruitment plans.

Sep 30, 2020

New Ruipeng picks up funding

Tencent has led a round worth hundreds of millions of dollars for New Ruipeng, which is now valued at $4.4bn and also backed by Boehringer Ingelheim and Country Garden.

Sep 29, 2020

Palladio fills palette with $20m

Roche has injected funding into Palladio, creators of a drug for autosomal dominant polycystic kidney disease.

Sep 29, 2020

Palladio fills palette with $20m

OUP has injected follow-on funding into Palladio, creators of a drug for autosomal dominant polycystic kidney disease.

Sep 29, 2020

XtalPi calculates $319m series C

SoftBank Vision Fund 2, PICC Group and Morningside Venture Capital co-led the round, which also attracted Tencent, China Life Insurance, SIG China and others.

Sep 28, 2020

Investors deliver $300m to Rappi

Delivery Hero and SoftBank-backed Rappi has picked up more than $300m from a group of investors including T. Rowe Price Associates.

Sep 28, 2020

Tencent helps transfer $176m to Taimei

Tencent joined GL Ventures and YF Capital to co-lead a $176m funding round for Taimei Technology, while SoftBank China Venture Capital also invested.

Sep 28, 2020

InventisBio ignites $147m series D

Lilly Asia Ventures has returned for a $147m series D round that will allow InventisBio to advance its treatments for breast cancer and gout into phase 2 clinical trials.

Sep 28, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here